Concord Biotech Limited has announced that its Board of Directors has fixed Wednesday, November 04, 2026, as the record date for determining eligibility for bonus equity shares. The company plans to issue bonus shares in a 1:1 ratio, meaning one bonus share for every existing fully paid-up share held, subject to necessary approvals. The deemed date for allotment of these shares will be Thursday, November 05, 2026.
Concord Biotech Announces Bonus Share Record Date
Concord Biotech Limited has officially set Wednesday, November 04, 2026, as the record date for the issuance of bonus equity shares. This decision was made by the Board of Directors during a meeting held on October 27, 2026.
Bonus Share Ratio and Allotment
The bonus equity shares will be issued in the ratio of 1:1. This means that shareholders will receive one bonus equity share for every one existing fully paid-up share they hold. This issuance is subject to obtaining all applicable statutory and regulatory approvals.
Further to the record date, the deemed date for the allotment of these bonus equity shares has been fixed as Thursday, November 05, 2026. This aligns with the guidelines provided by SEBI.
Source: BSE
